Latin American Pharmaceutical Gelatin Market Size

The Latin America pharmaceutical gelatin market was worth USD 0.10 billion in 2025. The global market is predicted to reach USD 0.11 billion in 2026 and USD 0.19 billion by 2034, growing at a CAGR of 7.11% from 2026 to 2034.

MARKET DRIVERS

Rising pharmaceutical demand, clean label trends, and capsule innovation fuel gelatin market growth

The pharmaceutical gelatine market in Latin America is primarily driven by rising demand for useful and convenient food and beverage items, expanding pharmaceutical uses, and a growing need for clean label products. In addition, gelatine's unique and functional qualities in pharmaceutical applications and chronic illness prevalence due to an increasing population drive market expansion.

In addition, the expansion of the Latin American pharmaceutical gelatine market is further influenced by gelatine production in capsule creation in the rising market. Furthermore, increased product flexibility, strength, consistency, safety stability, and better efficacy in hard capsules are likely to drive market expansion. Furthermore, pharmaceutical gelatine has several technological benefits over non-gelatine excipients such as HMPC in hard capsules, and modified starch in soft gels is expected to boost the market growth.

Growth in the prevalence of COVID-19 across the continent is also fuelling the pharmaceutical industry's demand.

Due to the resumption of previously postponed activity, the second half of the epidemic is likely to impact growth positively. Manufacturers are concentrating on gelatine capsules, and research has increased since the lockdown was lifted. Therefore, during the anticipated period, the market is expected to rise faster.

MARKET RESTRAINTS

Vegan shift, raw material cost surge, and strict animal-sourcing laws restrict gelatin market growth

The most significant restriction for the Latin American pharmaceutical gelatine market is the growing popularity of veganism. Veganism is currently popular in the marketplace. This trend spreads worldwide, with producers creating non-gelatine or vegetarian capsules made entirely of plant components to fulfill consumer expectations. Therefore, pharmaceutical gelatine is likely to be restrained by rising demand for plant-based medications and changes in product portfolios throughout the forecast period.

The key difficulty is the growth in raw material prices and the acquisition of raw material availability. The majority of gelatine is extracted in slaughterhouses and meat processing plants. In addition, most governments have tight laws in place for handling materials to prevent the spread of diseases caused by animal-borne pathogens, which impacts the supply of export or import in any location at any given moment.

REPORT COVERAGE

COUNTRY LEVEL ANALYSIS

There are plenty of bovine and porcine raw material sources available in Latin America and reasonably priced labor and capital inputs.

As a result, many of the market's major companies are making investments in this region. During the forecast period, the pharmaceutical gelatine market in Latin America is expected to grow rapidly. The availability of diverse raw material sources in this region and active participation by market players has fuelled market expansion in this region throughout the years.

The usage of high-quality collagen in bone and tissue restoration patches is expected to boost the market growth. In addition, the gelatine market in Latin America is influenced by consumer demand for gelatine-based items such as food, cosmetics, rejuvenation beverages, and pharmaceuticals.

The Brazilian pharmaceutical gelatin market is expected to dominate the Latin American market during the forecast period. Factors such as rising pharmaceutical industry applications and rising chronic illness prevalence due to a growing population are expected to drive gelatine market expansion in this region over the forecast period.

After Brazil, Argentina is predicted to hold a promising share of the Latin American pharmaceutical gelatine market. Factors such as an increase in chronic disease, a rise in the senior population, the availability of modern healthcare facilities, and favorable government regulations are expected to boost the market growth.

KEY MARKET PLAYERS

Some of the major companies dominating the market by their products and services include Rousselot, Nitta Gelatin Inc., Capsugel, Catelent Inc., Norland Products Inc, Tessenderlo Group, Sterling Gelatin, Roxlor LLC, Weishardt, and Gelita AG. 

MARKET SEGMENTATION

This Latin America pharmaceutical gelatin market research report is segmented and sub-segmented into the following categories.

By Function

• Stabilizers
• Thickeners        
• Gelling Agents     

By Source

• Pig Skin
• Bovine Hides
• Bones 
• Others

By Application

• Hard Capsules     
• Soft Capsules      
• Micro Encapsulation      
• Coating   
• Absorbable Hemostats   

By Country

• Brazil
• Mexico
• Argentina
• Chile
• Rest of Latin America